Only COVID-19 patients who have pre-existing conditions that require the usage of anticoagulant and antiplatelet drugs must continue its intake.
Therefore, COVID-19 patients who experience an incident thromboembolic events should take antiplatelet therapy after discharge, with the doctor's consultation. The quantity of those medicines depends on patients' conditions
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.